Cryoablation devices market seen reaching $0.96 billion by 2030

The cryoablation devices market is projected to grow from $0.61 billion in 2025 to $0.96 billion by 2030, driven by rising cardiovascular disease, cancer treatment demand and broader use of minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the next several years.

Why it matters: - Cryoablation devices are gaining traction as hospitals and clinics look for less invasive ways to treat tumors and cardiac arrhythmias. - The market’s growth signals rising demand for procedures that can preserve healthy tissue, shorten recovery and expand outpatient treatment options. - The Business Research Company expects the market to nearly double by 2030, reaching $0.96 billion.

What happened: - The Business Research Company published its Cryoablation Devices Market Report 2026, covering market size, trends and global forecasts through 2035. - The report says the market will grow from $0.61 billion in 2025 to $0.67 billion in 2026. - The report forecasts a 9.2% CAGR from 2026 to 2030. - The company also provides a free sample report and the full market report through the sample download and the full report.

The details: - Cryoablation devices use extreme cold to destroy abnormal tissue. - The devices are used to treat tumors and malfunctioning cardiac tissue. - Growth in recent years has been tied to more cancer and cardiac arrhythmia cases. - Demand has also increased as providers favor minimally invasive therapies. - The report points to expansion in interventional oncology and cardiac electrophysiology services. - Improved clinical outcomes from cryoablation treatments are another factor supporting adoption. - The report expects further growth from organ-preserving cancer treatments, greater use in early-stage disease management, specialty treatment center expansion and ongoing probe and system innovation. - Key market trends include broader use in oncology and cardiology, more image-guided procedures, growth in outpatient and ambulatory services, and higher demand for precision-controlled tissue ablation. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - New 2026 report features include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - Rising cardiovascular disease rates appear to be a core demand driver because cryoablation is widely used to treat arrhythmias such as atrial fibrillation. - Higher healthcare spending is making advanced procedural technologies easier for providers to adopt. - The regional split suggests mature adoption in North America and faster capacity buildout across Asia-Pacific. - The report’s emphasis on outpatient, ambulatory and image-guided procedures points to continued migration away from traditional surgery.

What's next: - The market is expected to keep expanding as more health systems adopt cryoablation for oncology and cardiology. - Growth will likely depend on continued device innovation, wider specialty-center deployment and rising use in early disease treatment. - The company is promoting direct access to its research team and report materials through its contact channels and social platforms. - More information is available through the company’s announcement.